Persante Health Care, Inc.

Persante Health Care, Inc. specializes in providing innovative sleep management solutions targeting sleep disorders, including insomnia and obstructive sleep apnea, through advanced diagnostic and operational tools. Founded in 2012 and based in the US, Persante Health Care, Inc. focuses on enhancing sleep care solutions.

The company has engaged in two significant deals, with the most recent occurring on April 10, 2013. The leadership team includes CEO Carmen Nepa and Vyto Kab, ensuring strategic oversight of operations. Persante offers a comprehensive suite of sleep management solutions, including advanced home sleep apnea testing (HSAT) devices, diagnostic equipment, and operational management tools. The company collaborates with healthcare providers across the US to improve patient outcomes through tailored solutions that streamline diagnostic processes and provide educational resources for patients and professionals.

Persante generates revenue primarily through partnerships with healthcare institutions, providing operational support for sleep centers. Revenue is derived from contract agreements that include service fees for diagnostic testing and access to proprietary technology. The company's services are structured around a B2B model to maintain long-term relationships with healthcare providers, fostering consistent revenue growth. Persante aims to expand its product offerings with new diagnostic tools and operational software, slated for release in the upcoming fiscal year.

The company plans to enter new geographic markets, specifically targeting regions that have seen an increase in sleep disorder diagnoses by the end of 2024. Recent funding from the deal on April 10, 2013, will be allocated to support these product developments and market expansions.